Detection of human papillomaviruses

a human papillomavirus and detection method technology, applied in the field of human papillomavirus detection, can solve the problems of low detection efficiency, low detection efficiency, and inability to reliably detect all hpv viruses

Inactive Publication Date: 2005-06-07
UNIV TUBINGEN
View PDF9 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The technical effect of this patented method is that it can accurately identify any strains of human papillomavirus (HPV) that may cause cancer. This allows for more precise treatment options based on their presence or absence.

Problems solved by technology

The technical problem addressed in this patent text relates to the limitations of current methods for identifying and quantitative analysis of HPVs, especially those with intermediate levels of residual activity. Current methods require multiple steps and may miss important ones due to insufficient sensitivity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection of human papillomaviruses

Examples

Experimental program
Comparison scheme
Effect test

example 1

DNA Extraction

[0054]For the purpose of detecting HPV, it is first of all necessary to remove biopsy or smear material. This is taken up in 500 μl of melting buffer (0.1 M EDTA; 0.05 M Tris, pH 8.0; 0.5% SDS). 2.5 μl of proteinase K (20 mg / ml) are then added to this and the solution is incubated at 55° C. for from 24 to 48 hours.

[0055]This is then followed by two extractions with phenol (phenol:CHCl3:isoamyl alcohol=25.24:1). The preparation is mixed, not vortexed, incubated for 2-5 min. (rotated with inversion), and, after that, centrifuged at 14 000 rpm for 5 min. There then follows an extraction with CHCl3 / isoamyl alcohol (24:1) and incubation for 2-5 min and, after that, a centrifugation at 14 000 rpm for 5 min.

[0056]{fraction (1 / 10)} of the preparation volume of 7.5 M ammonium acetate is then added and the preparation is mixed and incubated at 55° C. for from 2 to 4 hrs.

[0057]The preparation is then precipitated with ethanol at −20° C. overnight.

[0058]The DNA which has been e

example 2

PCR Reaction

[0059]The PCR is used for selectively amplifying viral DNA segments.

[0060]0.25 μl, 1 μl, 2.5 μl and 5 μl of the extracted quantity of DNA are used for this purpose (without the concentration being determined); additions: primer 1: 100 ng, primer 2; 100 or 200 ng, dNTPs: in each case 10 mM; 5 μl of Taq polymerase buffer (10-fold, without MgCl2); 7 μl of MgCl2 (25 mM stock solution, corresponds to 3.6 mM); 0.4 μl of Taq Gold polymerase (corresponds to 2 units). The preparation is made up to a total volume of 50 μl. The PCR is performed in an MJ-Research Thermocycler (PTC 200); set heating rate: 1° C. / sec. The PCR amplification takes place over 40 cycles [10 min. 95° C. (heating, only in the first cycle); 30 sec. 95° C.; 30 sec. 55° C.; 1 min. 72° C.; 5 min. 72° C. (cooling, only in the last cycle)].

[0061]For the purpose of nonspecifically detecting an HPV infection (screening), preference is given to using the sequences SEQ ID No. 1 (forward) and SEQ ID No. 2 (backward) as

example 3

DNA Sequencing (Typing)

[0067]The sequencing of the amplificate from Example 2, for the purpose of identifying the HPV type, is carried out using the ABI Big Dye Terminator Cycle Sequencing Ready Reaction Kit containing Ampli-Taq and using 200 ng of primer SEQ ID No. 1 or SEQ ID No. 3 and the PCR amplification preparation. This latter has previously been concentrated and purified through Microcon 100 columns (Millipore). Approx. 50% of the purified preparation is used for the sequencing.

[0068]The sequencing PCR reaction is carried out in accordance with the following conditions: 10 sec. 96° C., 5 sec. 55° C., 4 min. 60° C., 30 cycles, with a heating rate of 1° C. / sec.

[0069]There then follows a precipitation with 0.3 M sodium acetate and 2.5 times the volume of ethanol.

[0070]The pellet is taken up in 25 μl of TSR (template suppression reagent from ABI), incubated at 90° C. for 2 min. and, after that, brought to 4° C. for 2 min. and subsequently kept at room temperature.

[0071]The capill

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Login to view more

Abstract

A method for detecting human papillomaviruses (HPV) in biological material is described, in which method nucleic acids are extracted/isolated from biological material and HPV-specific DNA is detected in the isolated nucleic acids. This method uses at least one of the nucleotide sequences SEQ ID No. 1 or SEQ ID No. 2 from the enclosed sequence listing or sequences which bind to sequences to which one of the sequences SEQ ID No. 1 or SEQ ID No. 2 binds or sequences which are complementary to the abovementioned sequences.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner UNIV TUBINGEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products